CETP TaqIB genotype shapes HDL cholesterol but not diabetes risk in Southern Thai adults (Arch Med Res 2018)

Apolipoprotein E (APOE) and cholesteryl ester transfer protein (CETP) play an important role in the lipid metabolism. Dyslipidemia is one of the complications that found in type 2 diabetes mellitus (T2DM) patients. The aim of this study was to investigate the association of APOE and CETP TaqIB polymorphisms with T2DM and its related metabolic parameters in Southern Thai population. Study subjects were 241 T2DM patients and 275 healthy controls. The APOE and CETP TaqIB polymorphisms were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. APOE polymorphism showed a statistical difference in allele frequencies (p = 0.025) and genotype distributions (p <0.001) between T2DM patients and healthy controls. The E4 carriers were associated with a significantly higher TC, and/or LDL-C levels compared to the E2 and E3 carriers, respectively in all subjects and healthy controls. Moreover, CETP TaqIB B2B2 genotype was significantly higher HDL-C levels compared with B1B1, and B1B2 genotypes in all subjects, and T2DM patients. Multiple logistic regression analysis showed that APOE and CETP TaqIB polymorphisms were not associated with T2DM. In conclusion, APOE and CETP TaqIB polymorphisms might not be the genetic risk factors for T2DM in Southern Thai population, however, APOE and CETP TaqIB polymorphisms were associated with serum lipids in healthy controls and T2DM, respectively.